Company · CIK 0001815442 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Kymera Therapeutics, Inc. · KYMR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 4, 6:00 pm EDT | Brian AdamsChief Legal Officer | 6,371 | $116.83 | $744,297 | 50,254 | −11.3% | |
| Jul 27, 2026 AForm 4 → | Jul 27, 6:34 pm EDT | Terence RooneyChief Medical Officer | 38,000 | — | — | 38,000 | — | |
| Jul 7, 2026 SForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | $119.00 | $5,950,000 | 666,568 | −6.98% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | $2.08 | $104,000 | 716,568 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Noah GoodmanChief Business Officer | 3,389 | $114.29 | $387,329 | 47,179 | −6.70% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | $115.29 | $9,223,527 | 666,568 | −10.7% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | $2.08 | $166,400 | 746,568 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 77,109 | $114.96 | $8,864,829 | 244,883 | −23.9% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 61,378 | $5.33 | $327,145 | 321,992 | — | 10b5-1 |
| Jun 29, 2026 SForm 4/A → | Jul 2, 5:39 pm EDT | Bruce BoothDirector | 76,650 | $108.05 | $8,281,905 | 462,856 | −14.2% | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 5:32 pm EDT | Bruce BoothDirector | 31,283 | $109.48 | $3,424,800 | 461,794 | −6.34% | 10b5-1 amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 AForm 4 → | Jul 27, 6:34 pm EDT | Terence RooneyChief Medical Officer | 76,000 | — | — | 76,000 | — | |
| Jul 7, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | — | — | 14,284 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | — | — | 135,559 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 61,378 | — | — | 0 | — | 10b5-1 |